News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,801 Results
Type
Article (2631)
Company Profile (44)
Press Release (38125)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (14231)
Career Advice (79)
Deals (2126)
Drug Delivery (9)
Drug Development (4165)
Employer Resources (10)
FDA (446)
Job Trends (788)
News (20341)
Policy (1057)
Tag
Academia (147)
Allergies (7)
Alliances (3492)
ALS (6)
Alzheimer's disease (64)
Antibody-drug conjugate (ADC) (45)
Approvals (454)
Artificial intelligence (38)
Autoimmune disease (18)
Automation (3)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (22)
Biotechnology (30)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (53)
Cancer (390)
Cardiovascular disease (13)
Career advice (66)
Career pathing (1)
CAR-T (38)
CDC (2)
Cell therapy (97)
Cervical cancer (4)
Clinical research (3537)
Collaboration (241)
Company closure (3)
Compensation (125)
COVID-19 (187)
CRISPR (12)
C-suite (148)
Cystic fibrosis (8)
Data (515)
Denatured (6)
Depression (12)
Dermatology (1)
Diabetes (19)
Diagnostics (500)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (43)
Drug pricing (10)
Duchenne muscular dystrophy (56)
Earnings (4633)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6552)
Executive appointments (146)
FDA (614)
Friedreich's ataxia (6)
Frontotemporal dementia (1)
Funding (203)
Gene editing (39)
Generative AI (3)
Gene therapy (67)
GLP-1 (75)
Government (162)
Guidances (24)
Healthcare (715)
HIV (3)
Huntington's disease (6)
IgA nephropathy (13)
Immunology and inflammation (37)
Immuno-oncology (16)
Indications (11)
Infectious disease (206)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (37)
Interviews (7)
IPO (1006)
IRA (7)
Job creations (294)
Job search strategy (62)
JPM (4)
Kidney cancer (7)
Labor market (12)
Layoffs (52)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (6)
Lung cancer (35)
Lymphoma (13)
Machine learning (3)
Management (4)
Manufacturing (72)
MASH (17)
Medical device (317)
Medtech (321)
Mergers & acquisitions (1248)
Metabolic disorders (92)
mRNA (10)
Multiple sclerosis (26)
Neurodegenerative disease (35)
Neuropsychiatric disorders (11)
Neuroscience (188)
NextGen: Class of 2026 (354)
Non-profit (157)
Now hiring (15)
Obesity (45)
Opinion (18)
Ovarian cancer (23)
Pain (32)
Pancreatic cancer (24)
Parkinson's disease (14)
Partnered (4)
Patents (66)
Patient recruitment (47)
Peanut (1)
People (5961)
Pharmaceutical (3)
Phase 1 (1518)
Phase 2 (1753)
Phase 3 (942)
Pipeline (622)
Policy (17)
Postmarket research (30)
Preclinical (656)
Press Release (2)
Prostate cancer (8)
Psychedelics (4)
Radiopharmaceuticals (17)
Rare diseases (80)
Real estate (425)
Recruiting (5)
Regulatory (953)
Reports (7)
Research institute (151)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (2)
Schizophrenia (17)
Series A (54)
Series B (25)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (500)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (5)
Vaccines (58)
Venture capital (16)
Weight loss (27)
Women's health (16)
Worklife (1)
Date
Today (22)
Last 7 days (77)
Last 30 days (271)
Last 365 days (2396)
2026 (884)
2025 (2443)
2024 (2611)
2023 (2873)
2022 (3762)
2021 (4050)
2020 (3475)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (46)
Alabama (3)
Arizona (20)
Asia (1978)
Australia (308)
California (1850)
Canada (285)
China (100)
Colorado (65)
Connecticut (18)
Delaware (9)
Europe (4089)
Florida (71)
Georgia (15)
Hawaii (2)
Idaho (3)
Illinois (26)
India (3)
Indiana (70)
Japan (21)
Kansas (15)
Kentucky (1)
Maryland (64)
Massachusetts (660)
Michigan (14)
Minnesota (26)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (156)
New York (96)
North Carolina (151)
Northern California (931)
Ohio (53)
Oklahoma (2)
Oregon (7)
Pennsylvania (132)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (2)
Southern California (750)
Tennessee (5)
Texas (177)
United States (3725)
Utah (5)
Virginia (14)
Washington D.C. (3)
Washington State (106)
West Virginia (1)
Wisconsin (15)
40,801 Results for "annexon biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annexon to Present at the Bank of America Securities Health Care Conference 2026
May 6, 2026
·
1 min read
Press Releases
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
·
1 min read
Press Releases
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
·
1 min read
Press Releases
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
·
1 min read
Press Releases
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
March 30, 2026
·
13 min read
Press Releases
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - March 16, 2026
March 16, 2026
·
1 min read
Press Releases
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
February 17, 2026
·
9 min read
Press Releases
Annexon Biosciences to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
1 min read
Neuroscience
Annexon Touts ‘Rapid’ and ‘Durable’ Improvements for Targeted Guillain-Barré Therapy
Jefferies analysts predict Annexon’s tanruprubart could be approved by mid-2026.
April 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
January 8, 2026
·
8 min read
1 of 4,081
Next
